Ordinary Medicine
Autor Sharon R. Kaufmanen Limba Engleză Hardback – 29 mai 2015
"
Preț: 771.72 lei
Preț vechi: 941.11 lei
-18%
Puncte Express: 1158
Carte tipărită la comandă
Livrare economică 18 iulie-01 august
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780822359029
ISBN-10: 0822359022
Pagini: 336
Dimensiuni: 155 x 236 x 23 mm
Greutate: 0.54 kg
Editura: Duke University Press
ISBN-10: 0822359022
Pagini: 336
Dimensiuni: 155 x 236 x 23 mm
Greutate: 0.54 kg
Editura: Duke University Press
Cuprins
Acknowledgments ix
Introduction. Diagnosing Twenty-First-Century Health Care 1
Part I: The Quandry and Unexamined Ordinariness of Twenty-First-Century Medicine
1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity 21
Part II. The Chain of Health Care Drivers
2. The Medical-Industrial Complex I: Evidence-Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials 53
3. The Medical-Industrial Complex II: Access, Industry, and the Clincial Trials Phenomenon 79
4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life 99
Part III: Medicine's Changing Means and Ends
5. Standard and Necessary Treatments: The Changing Means and Ends of Technology 127
6. Family Matters: Kidneys and New Forms of Care 165
7. Influencing the Character of the Future: Prognosis, Risk, and Time Left 195
8. For Whose Benefit? Our Shared Quandary 217
Conclusion. Toward a New Social Contract? 238
Notes on the Research 249
Notes 255
Bibliography 285
Index 307
Introduction. Diagnosing Twenty-First-Century Health Care 1
Part I: The Quandry and Unexamined Ordinariness of Twenty-First-Century Medicine
1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity 21
Part II. The Chain of Health Care Drivers
2. The Medical-Industrial Complex I: Evidence-Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials 53
3. The Medical-Industrial Complex II: Access, Industry, and the Clincial Trials Phenomenon 79
4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life 99
Part III: Medicine's Changing Means and Ends
5. Standard and Necessary Treatments: The Changing Means and Ends of Technology 127
6. Family Matters: Kidneys and New Forms of Care 165
7. Influencing the Character of the Future: Prognosis, Risk, and Time Left 195
8. For Whose Benefit? Our Shared Quandary 217
Conclusion. Toward a New Social Contract? 238
Notes on the Research 249
Notes 255
Bibliography 285
Index 307